At a glance
- Originator Mercian
- Class Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 08 Feb 2000 No-Development-Reported for Mycoses in Japan (Unknown route)
- 03 Apr 1997 Preclinical development for Mycoses in Japan (Unknown route)
- 20 Feb 1997 New profile